Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06795867 · ClinicalTrials.gov registry record · NA
Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
A NA study of Chronic Migraine, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06795867: Recruiting NA study of Chronic Migraine, sponsored by Brigham and Women's Hospital.
NCT06795867 is a NA study of Chronic Migraine that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants, below the 341-participant average among 17 other Chronic Migraine trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06795867, a NA study of Chronic Migraine, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if the behavioral treatment called Acceptance and Commitment Therapy (ACT) works to improve disability in adults with chronic migraine. The main questions it aims to answer are: Does the use of ACT added to usual treatment improve scores on questionnaires designed to measure daily functioning and activity? Does the use of ACT added to usual treatment improve scores on diaries designed to measure headache frequency and pain? Researchers will compare adding ACT to usual headache treatments to usual headache treatments without ACT. Participants who are selected for ACT will take 8 classes to learn ACT and then will practice it at home, in addition to their regular headache treatment. Those not selected will continue their regular headache treatment. Four times over the following year, participants will answer questions about their symptoms during each of four virtual visits. They will also keep a daily headache diary during the study
Primary Outcome
Change in Headache Disability Index from baseline to 3 months. Scores at 3 months minus scores at baseline.
Conditions Studied
Interventions
- BEHAVIORAL acceptance and commitment therapy
Study Locations (1)
Massachusetts
- Brigham and Women's / Faulkner Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2028-03 |
| Phase | NA |
What NCT06795867 shows while recruiting
NCT06795867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 341-participant average among 17 other Chronic Migraine trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Chronic Migraine appearing as the primary indexed condition, and to 1 intervention - of which acceptance and commitment therapy is the first listed.
NCT06795867 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06795867 about?
NCT06795867 is a clinical study titled "Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine". The goal of this clinical trial is to learn if the behavioral treatment called Acceptance and Commitment Therapy (ACT) works to improve disability in adults with chronic migraine. The main questions it aims to answer are: Does the use of ACT added to usual treatment improve scores on questionnaires...
What is the current status of trial NCT06795867?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-21. Estimated completion is 2028-03.
What conditions does trial NCT06795867 study?
This clinical trial studies the following conditions: Chronic Migraine.
What interventions are being tested in trial NCT06795867?
The interventions under investigation include: acceptance and commitment therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06795867?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06795867 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06795867's enrollment target sits among peer trials
40 16th of 17 higher than 2 of 17 other Chronic Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
-
Brief Interventions in Chronic Migraine
ACTIVE NOT RECRUITING · NA
-
Efficacy of Behavioral Insomnia Treatment for Chronic Migraine
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI